All Industries

Top Biotech Companies

7,741 Biotech companies, sorted by total funding raised.

ArvinasIPO

Arvinas develops targeted protein degradation medicines using its PROTAC platform for patients wi...

New Haven, United States201–500Biotech, Healthcare
Private EquityTotal funding$465.9MNov 2023
BiofourmisAcquired

AI-driven platform delivering remote patient monitoring and in-home care for health systems, paye...

Boston, United States201–500Artificial Intelligence, Digital Health
Series DTotal funding$461.5MJul 2022
Crinetics Pharmaceuticals, Inc.Acquired

Crinetics develops and commercializes therapies for endocrine diseases and endocrine-related tumo...

San Diego, United States11–50Biotech, Healthcare
Venture RoundTotal funding$460.3MJan 2026
Nektar TherapeuticsIPO

Research-based development stage biopharmaceutical company that discovers and develops innovative...

San Francisco, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$460.0MFeb 2026
ImmunomedicsAcquired

Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...

Morris Plains, United States201–500Biotech, Oncology
Private EquityTotal funding$459.0MMay 2020
Science.xyz

Clinical-stage medical technology company developing neural-engineering implants and platforms to...

Alameda, United States51–200Biotech, Medtech
Series CTotal funding$457.0MMar 2026
GalectoIPO

Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...

Copenhagen, Denmark11–50Biotech, Drug Discovery
Series CTotal funding$446.9MNov 2025
X4 PharmaceuticalsIPO

Clinical-stage biopharmaceutical company developing novel, oral medicines designed to treat a ran...

Boston, United States51–200Biotech, Drug Discovery
Series CTotal funding$446.8MOct 2025
Owkin

Owkin builds agentic AI scientists trained on multimodal patient data to help biopharma teams acc...

San Francisco, United States201–500Artificial Intelligence, Biotech
Corporate RoundTotal funding$445.2MJan 2023
Inventiva PharmaIPO

Inventiva develops an oral investigational therapy for MASH that targets metabolic dysfunction, i...

Daix, France51–200Biotech, Healthcare
Growth EquityTotal funding$444.7MMay 2025
Charles River LaboratoriesIPO

Charles River Laboratories provides essential products and services that help pharmaceutical, bio...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$443.0MSep 1999
Cue HealthClosed

Biotech company empowering personalized, proactive healthcare through at-home diagnostic testing.

San Diego, United States201–500Biotech, Healthcare
Series DTotal funding$440.0MMay 2021
Helix

Population genomics and viral surveillance company enabling health systems and public health orga...

San Mateo, United States201–500Biotech, Diagnostics
Series CTotal funding$435.0MJun 2021
Korro BioIPO

Privately held biotechnology company developing precision genetic medicines using RNA editing for...

Cambridge, United States51–200Biotech, Healthcare
Private EquityTotal funding$430.0MMar 2026
Ollin Biosciences

Clinical-stage biopharmaceutical company dedicated to developing best-in-disease therapies for vi...

Austin, United States11–50Biotech, Healthcare
Series BTotal funding$430.0MJun 2026
Verve TherapeuticsAcquired

Verve Therapeutics develops gene-editing treatments for atherosclerotic cardiovascular disease us...

Boston, United States201–500Biotech, Drug Discovery
Series CTotal funding$428.5MOct 2024
Mineralys TherapeuticsIPO

Clinical-stage biopharmaceutical company developing treatments for cardiorenal metabolic syndrome.

Radnor, United States11–50Biotech, Healthcare
Corporate RoundTotal funding$428.0MJun 2026
AdvanCell

AdvanCell develops targeted alpha radiopharmaceutical therapies, using its vertically integrated ...

Sydney, Australia11–50Biotech, Healthcare
Venture RoundTotal funding$427.0MJul 2026
Areteia TherapeuticsClosed

Clinical-stage biotechnology company formerly based in Chapel Hill that is no longer operating an...

Chapel Hill, United States11–50Biotech, Life Sciences
Series ATotal funding$425.0MFeb 2024
ATAIIPO

Clinical-stage biopharmaceutical company developing psychedelic-based treatments for mental healt...

Berlin, Germany51–200Biotech, Mental Health
Private EquityTotal funding$422.4MJul 2025
Allogene TherapeuticsIPO

Clinical-stage biotechnology company developing allogeneic CAR T cell therapies for blood cancers...

South San Francisco, United States51–200Biotech, Healthcare
Series ATotal funding$420.0MApr 2018
Scorpion TherapeuticsAcquired

Clinical-stage precision oncology company developing transformational targeted therapies for canc...

Boston, United States51–200Biotech, Healthcare
Series CTotal funding$420.0MJul 2024
RayzeBio

RayzeBio advances radiopharmaceutical therapies for people with cancer, developing targeted treat...

United StatesBiotech, Healthcare
Series CTotal funding$418.0MSep 2022
Benchling

Benchling provides a cloud platform for life sciences R&D, helping scientific teams plan experime...

San Francisco, United States501–1000Biotech, SaaS
Series G+Total funding$412.0MNov 2021
Enzene Biosciences

Global biologics CDMO specializing in biosimilars development, manufacturing, and continuous biop...

India501–1000Biotech, Manufacturing
Private EquityTotal funding$412.0MDec 2025